[Venetoclax (chronic lymphocytic leukaemia; combination with rituximab) - Addendum to Commission A18-81]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 1953229179
Original Title: Venetoclax (chronische lymphatische leukämie; kombination mit Rituximab) – Addendum zum Auftrag A18-81
Project Status: Completed
Year Published: 2019
English language abstract: An English language summary is available
Publication Type: Other
Country: Germany
MeSH Terms
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Antineoplastic Combined Chemotherapy Protocols
  • Antineoplastic Agents
  • Bendamustine Hydrochloride
  • Bridged Bicyclo Compounds, Heterocyclic
  • Rituximab
  • Venetoclax
  • Leukemia – Lymphocytic – Chronic – B-Cell
  • Benefit Assessment
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.